Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesPsoriasis and Atherothrombotic Diseases: Disease-Specific and Non-Disease-Specific Risk Factors
Seminars in Thrombosis and Hemostasis, 05/26/09
Gisondi P et al. - The presence of cardio-metabolic comorbidities has also relevant implication in the therapy and global approach to patients with psoriasis. Traditional systemic antipsoriatic agents frequently negatively affect cardio-metabolic comorbidities and may have important interactions with drugs commonly used by psoriasis patients. Thus, patients with psoriasis should be treated effectively and encouraged to aggressively correct their modifiable cardiovascular risk factors.
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
A practical approach to using methotrexate
Dermatology in Practice, 10/09/09
Therapeutic options for palmoplantar pustulosis
Clinical and Experimental Dermatology, 11/16/09
Adalimumab for psoriasis patients who are non-responders to etanercept: open-label prospective evaluation
Journal of the European Academy of Dermatology and Venereology, 11/23/09
Sponsor
Article Search
Sponsor